Azaquinazoline Inhibitors Of Atypical Protein Kinase C
申请人:Ignyta, Inc.
公开号:US20150274720A1
公开(公告)日:2015-10-01
The present application provides a compound of formula (I)
and/or a salt thereof, wherein R
1
, G, and X are as defined herein. A compound of formula (I) and/or its salts have aPKC inhibitory activity, and may be used to treat proliferative disorders. Compositions comprising a compound of Formula (I) and/or a salt thereof are also provided.
Compounds of formula (I) which are inhibitors of Bub1 kinase, processes for their production and their use as pharmaceuticals.
式(I)的化合物是Bub1激酶的抑制剂,其制备方法及其作为药物的用途。
A study of the photochemically induced reaction of pyridine-2,4-dicarbonitrile with primary and secondary amines. A direct synthesis of aminocyano-pyridines
作者:Rosanna Bernardi、Tullio Caronna、Sergio Morrocchi、Maurizio Ursini、Bruno M. Vittimberga
DOI:10.1039/p19900000097
日期:——
A novel synthesis of alkylaminopyridinecarbonitriles by a photoinitiated substitution reaction between pyridine-2,4-dicarbonitrile and certain amines is described. The mechanism is discussed.
The invention is directed to Compounds of Formula I:
as well as methods of making and using the compounds.
本发明涉及式I的化合物,以及制备和使用该化合物的方法。
[EN] TYK2 INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE TYK2 ET LEURS UTILISATIONS
申请人:SUDO BIOSCIENCES LTD
公开号:WO2022136914A1
公开(公告)日:2022-06-30
Described herein are compounds that are TYK2 inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders that would benefit from modulation of TYK2 activity.